MedicalCRITERIA.com

Unifying Concepts

Lung Reporting and Data System (Lung-RADS)

The Lung CT Screening Reporting and Data System (Lung-RADS) is an algorithm that can be used to classify lung nodules in patients with significant smoking histories.

Lung Reporting and Data System (Lung-RADS)

 

Category Descriptor Criteria Category Management
Incomplete 0 Additional lung cancer screening CT images and/or comparison to prior chest CT examinations is needed
Negative No nodules and definitely benign nodules (nodule(s) with specific calcifications: complete, central, popcorn, concentric rings and fat containing nodules). 1 Continue annual screening with low-dose CT (LDCT) in 12 months. Risk of cancer <1%
Benign Appearance or Behavior Nodules with a very low likelihood of becoming a clinically active cancer due to size or lack of growth. Solid nodule(s) < 6 mm or new < 4 mm; part solid nodule(s) < 6 mm total diameter on baseline screening; non solid nodule(s) (ground glass nodules – GGN) < 20 mm OR >/= 20 mm and unchanged or slowly growing; category 3 or 4 nodules unchanged for >/= 3 months 2
Probably benign Probably benign finding(s) – short term follow up suggested; includes nodules with a low likelihood of becoming a clinically active cancer. Solid nodule(s) >/= 6 to < 8 mm at baseline OR new 4 mm to < 6 mm; part solid nodule(s) >/= 6 mm total diameter with solid component < 6 mm OR new < 6 mm total diameter; non solid nodule(s) (GGN) >/= 20 mm on baseline CT or new 3 Repeat chest CT in 6 months. Risk of cancer 1-2%.
Suspicious Findings for which additional diagnostic testing and/or tissue sampling is recommended.

  • 4A: Solid nodule(s) >/= 8 to < 15 mm at baseline OR growing < 8 mm OR new 6 to < 8 mm; part solid nodule(s) >/= 6 mm with solid component >/= 6 mm to < 8 mm OR with a new or growing < 4 mm solid component; endobronchial nodule
  • 4B: Solid nodule(s) >/= 15 mm OR new or growing, and >/= 8 mm; part solid nodule(s) with a solid component >/= 8 mm OR a new or growing >/= 4 mm solid component
4A 3 month LDCT; PET/CT may be used when there is a >/= 8 mm solid component. 5-15% risk of cancer
4B Chest CT with or without contrast, PET/CT and/or tissue sampling depending on the probability of malignancy and comorbidities. PET/CT may be used when there is a >/= 8 mm solid component. >15% risk of cancer
Other Clinically significant or potentially clinically significant findings (non lung cancer) S As appropriate to the specific finding
Prior Lung Cancer Modifier for patients with a prior diagnosis of lung cancer who return to screening C

 

References:

  1. Manos D, Seely JM, Taylor J, Borgaonkar J, Roberts HC, Mayo JR. The Lung Reporting and Data System (LU-RADS): a proposal for computed tomography screening. Can Assoc Radiol J. 2014 May;65(2):121-34. [Medline]
  2. van Riel SJ, Ciompi F, Jacobs C, Winkler Wille MM, Scholten ET, Naqibullah M, Lam S, Prokop M, Schaefer-Prokop C, van Ginneken B. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines. Eur Radiol. 2017 Oct;27(10):4019-4029. [Medline]
  3. Martin MD, Kanne JP, Broderick LS, Kazerooni EA, Meyer CA. Lung-RADS: Pushing the Limits. Radiographics. 2017 Nov-Dec;37(7):1975-1993. [Medline]

 

Created Jan 08, 2018

  • Language:

  • Users Online

  • Medical Disclaimer

    El contenido de este sitio web son solo para fines informativos y no reemplazan la consulta con un profesional médico.
  • Recent Posts

  • Categories

  • Copyright by MedicalCriteria.com